MDX

MDX

Fluxergy announces NIAID collaboration

LABline

Nov. 21, 2024

This announcement follows the news of a previous partnership launched earlier this year for Fluxergy.

MDX

Q&A with Nathan Patton, vice president of marketing for Near Patient Care at Roche Diagnostics

MLO Staff

Oct. 30, 2024

MDX

Q&A with Jackie Weiss, PhD, scientific affairs liaison at EUROIMMUN US (part of Revvity)

MLO Staff

Oct. 29, 2024

MDX

MLO releases findings of 2024 SOI survey on MDx

Kara Nadeau

Oct. 28, 2024

6661ca9ac16d6195f8f80048soi_featureditem

MDX

State of the Industry: Molecular Diagnostics 2024 survey open through September 6

LABline

Aug. 22, 2024

MDX

Navigating the landscape of hepatitis B: Symptoms, causes, and testing

Youssef Maakaroun

June 24, 2024

MDX

Diasorin receives FDA 510(K) Clearance for the LIAISON PLEX Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX

LABline

June 6, 2024

It is the second multiplexing molecular diagnostic panel on the LIAISON PLEX to be cleared by the U.S. FDA after the Respiratory Flex Assay, which received clearance in March ...

MDX

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG Respiratory Pathogen Panel v2

LABline

May 20, 2024

NxTag Respiratory Pathogen Panel (RPP) v2 is a molecular multiplex panel that detects 21 different pathogens (bacteria, viruses).

MDX

Revvity’s EUROIMMUN and ALPCO-GeneProof announce strategic partnership to expand CE-IVD molecular assay offerings

LABline

May 7, 2024

New diagnostic partnership.

MDX

Next-generation sequencing in laboratory medicine

Rajasri Chandra, MS, MBA

April 22, 2024

Advancements in sequencing techniques and the emergence of next-generation sequencing (NGS) technology have transformed laboratory medicine and clinical diagnosis. DNA sequencing...

MDX

PathogenDx launches novel D3 Array multiplexed molecular diagnostics technology for UTI pathogen detection and antibiotic resistance

LABline

Feb. 8, 2024

New product.

MDX

Molecular diagnostics research featured in the January issue of ADLM’s The Journal of Applied Laboratory Medicine

LABline

Jan. 17, 2024

Molecular diagnostics is a powerful branch of laboratory medicine that examines the fundamental genetic and biochemical components of life to provide invaluable insights into ...

MDX

Factors to consider in molecular diagnostics testing during the preanalytical phase

Dr. Eric Gonzalez Garcia

Dec. 18, 2023

Molecular diagnostics applies techniques of molecular biology to diagnose disease, as well as predict its course; select appropriate treatments; and monitor treatments’ ...

MDX

Revvity launches EONIS Q system enabling faster, simplified newborn screening for SMA and SCID

LABline

Nov. 27, 2023

Molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.

MDX

For bloodstream infection testing, don’t forget the fungal pathogens

Chris Gardner

Nov. 20, 2023

To take the test online go HERE. For more information, visit the Continuing Education tab. LEARNING OBJECTIVES Upon completion of this article, the reader will be able to: 1. ...

MDX

Molecular diagnostics (MDx) testing expands while lab supply shortages shrink

Kara Nadeau

Oct. 18, 2023

The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation...